Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Anna Bujak"'
Autor:
Guislain Hector, Estelle Appert, Hervé Roussel, Anna Bujak, Eirini Sarigiannidou, Vincent Consonni
Publikováno v:
Nanomaterials, Vol 14, Iss 12, p 991 (2024)
The development of innovative heterostructures made of ZnO nanowires is of great interest for enhancing the performances of many devices in the fields of optoelectronics, photovoltaics, and energy harvesting. We report an original fabrication process
Externí odkaz:
https://doaj.org/article/1d5c633150d545269d9e168bb9d74b97
Autor:
Maria Dulak-Lis, Anna Bujak, Kamila Gala, Martyna Banach, Urszula Kędzierska, Joanna Miszkiel, Joanna Hucz-Kalitowska, Michał Mroczkiewicz, Bartosz Stypik, Krzysztof Szymczak, Paweł Gunerka, Krzysztof Dubiel, Beata M. Zygmunt, Maciej Wieczorek, Jerzy S. Pieczykolan
Publikováno v:
Journal of Pharmacological Sciences, Vol 145, Iss 4, Pp 340-348 (2021)
Systemic lupus erythematosus is a chronic inflammatory disease, in which treatment is still limited due to suboptimal efficacy and toxicities associated with the available therapies. JAK kinases are well known to play an important role in systemic lu
Externí odkaz:
https://doaj.org/article/68149f6ba7294e63ad8e5e6d2edd988c
Autor:
Anna Bujak, Jerzy Pieczykolan, Maciej Wieczorek, Maria Dulak-Lis, Joanna Hucz-Kalitowska, Krzysztof Szymczak, Martyna Banach, Joanna Miszkiel, Kamila Gala, Bartosz Stypik, Michal Mroczkiewicz, Krzysztof Dubiel, Pawel Gunerka, Beata M. Zygmunt, Urszula Kędzierska
Publikováno v:
Journal of Pharmacological Sciences, Vol 145, Iss 4, Pp 340-348 (2021)
Systemic lupus erythematosus is a chronic inflammatory disease, in which treatment is still limited due to suboptimal efficacy and toxicities associated with the available therapies. JAK kinases are well known to play an important role in systemic lu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17cd3d46b00da284d2e784879aac9573
https://doi.org/10.1016/j.jphs.2021.02.002
https://doi.org/10.1016/j.jphs.2021.02.002
Autor:
Aleksandra Stanczak, Maciej Wieczorek, Anna Bujak, Lukasz Bojarski, Agata Klejman, Sylwia Janowska, Monika Lamparska-Przybysz, Andrzej K. Bednarek, Pawel Gunerka, Maria Mazur, Mikołaj Matłoka
Publikováno v:
Analytical Biochemistry. 475:56-67
Deregulation of the Wnt/β-catenin signaling pathway is associated with many serious disorders, including cancer and Alzheimer's disease. The pivotal player is β-catenin, which avoids degradation after activation of the pathway and is translocated t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eafcfffe355f05e3923a22fd8f75b7d
https://doi.org/10.1016/j.ab.2015.01.016
https://doi.org/10.1016/j.ab.2015.01.016
Autor:
Filip Stefaniak, Anna Bujak, Pawel Gunerka, Krzysztof Dubiel, Daria Zdzalik, Karolina Dzwonek, Paulina Grygielewicz, Monika Lamparska-Przybysz, Marcin Zagozda, Maciej Wieczorek, Barbara Dymek
Publikováno v:
MedChemComm. 6:1564-1572
TRAF-2 and NCK-interacting kinase (TNIK) is a serine–threonine kinase with a proposed role in Wnt/β-catenin and JNK pathways. Due to its implication in Wnt-mediated colorectal carcinogenesis, selective TNIK inhibition has emerged as an attractive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58056c76e4d05cc2a10ba770afa8bf3e
https://doi.org/10.1039/c5md00090d
https://doi.org/10.1039/c5md00090d
Autor:
Pawel Gunerka, Maciej Wieczorek, Monika Lamparska-Przybysz, Karolina Dzwonek, Daria Zdzalik, Anna Bujak, Barbara Dymek, Aleksandra Stanczak, Paulina Grygielewicz
Publikováno v:
Gastric Cancer
Background Up to 10 % of primary gastric cancers are characterized by FGFR2 amplification, and fibroblast growth factor receptor (FGFR) inhibitors may represent therapeutic agents for patients with these malignancies. However, long-term benefits of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9c8ad45242610a668a8bc3c5c9a4f14
https://doi.org/10.1007/s10120-014-0444-1
https://doi.org/10.1007/s10120-014-0444-1
Autor:
Heman Chao, Magdalena Winiarska, Radoslaw Zagozdzon, Katarzyna Poplawska, Wah Wong, Magdalena Ozga, Lukasz Szewczyk, Anna Bujak, Justyna Karolczak, Baomin Tian, Marni D. Uger, Pawel Wisniewski, Angelika Muchowicz, Beata Pyrzynska, Dorota Gierej, Abdessamad Zerrouqi
Publikováno v:
Cancer Research. 78:3919-3919
Introduction: Vascular endothelial growth factor receptor type 2 (VEGFR2) expression is one of the most prominent biomarkers of the tumor-associated neovasculature. Moreover, VEGFR2 can be aberrantly expressed on the surface of tumor cells. We have p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26a1bb3f60719682d807ca49249b7134
https://doi.org/10.1158/1538-7445.am2018-3919
https://doi.org/10.1158/1538-7445.am2018-3919
Autor:
Sekular Mariola, Pawel Turowski, Marcin Zagozda, Anna Bujak, Maciej Wieczorek, Maciej Dziachan, Joanna Hucz-Kalitowska, Pawel Gunerka
Publikováno v:
5.1 Airway Pharmacology and Treatment.
Introduction: Phosphoinositide 3-kinases (PI3K) are lipid kinases involved in multiple biological processes, such as cell proliferation, differentiation and survival. PI3Kδ isoform is expressed predominantly in immune cells and contributes to innate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7b52c6d2b85127e57890734834cd062
https://doi.org/10.1183/13993003.congress-2015.pa2123
https://doi.org/10.1183/13993003.congress-2015.pa2123
Autor:
Joanna Lipner, Bartosz Stypik, Maciej Wieczorek, Pawel Gunerka, Michal Mroczkiewicz, Anna Bujak, Pawel Turowski
Publikováno v:
5.1 Airway Pharmacology and Treatment.
Introduction: Role of interleukins 4 and 13 was confirmed in allergic asthma pathogenesis driven by Th 2 cells. Both cytokines signal through common γ-chain receptors, associated with JAK/STAT pathway. Janus kinases (JAKs) are responsible for immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52d9fdaf29802886bf13d5cc5007e9fd
https://doi.org/10.1183/13993003.congress-2015.pa2124
https://doi.org/10.1183/13993003.congress-2015.pa2124
Autor:
Anna Bujak, Karolina Dzwonek, Pawel Gunerka, Tadeusz Pietrucha, Monika Lamparska-Przybysz, Paulina Grygielewicz, Pawel Turowski, Aleksandra Stanczak, Barbara Dymek, Maciej Wieczorek
Publikováno v:
European journal of pharmacology. 765
Janus kinase (JAK) inhibitors are a promising treatment strategy in several hematological malignancies and autoimmune diseases. A number of inhibitors are in clinical development, and two have already reached the market. Unfortunately, all of them ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84b91fc7374645fb3a189cb0f02346a5
https://pubmed.ncbi.nlm.nih.gov/26300391
https://pubmed.ncbi.nlm.nih.gov/26300391